Alkermes (ALKS) Posts Narrower Q2 Loss, Ups 2016 Outlook
Zacks Equity Research - Zacks Investment Research - 2 hrs 5 mins ago
Alkermes (ALKS) reported a narrower-than-expected, second-quarter 2016 loss while revenues beat estimates; the company revised its outlook for 2016.
INVA: 13.09 (+1.39), FCSC: 1.09 (unch), ANIP: 60.18 (+0.57), ALKS: 49.29 (+1.16)
AstraZeneca (AZN) Beats on Q2 Earnings, Keeps 2016 View
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:16AM CDT
AstraZeneca (AZN) reported second-quarter 2016 core earnings of 83 cents per American Depositary Share, beating the Zacks Consensus Estimate of 42 cents.
INVA: 13.09 (+1.39), ANIP: 60.18 (+0.57), AZN: 34.14 (-0.15), NKTR: 16.90 (+0.80)
Innoviva Reports Second Quarter 2016 Financial Results
BusinessWire - Thu Jul 28, 3:05PM CDT
--U.S. TRx market share recently reached all-time highs of 10% for BREO and 8% for ANORO
INVA: 13.09 (+1.39)
Celgene (CELG) Tops Q2 Earnings & Revenues, Lifts View
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 11:11AM CDT
Celgene (CELG) reported better-than-expected second-quarter 2016 earnings and revenues; it once again raised the earnings outlook for 2016.
INVA: 13.09 (+1.39), FCSC: 1.09 (unch), ANIP: 60.18 (+0.57), CELG: 111.75 (+0.49)
Alexion (ALXN) Tops Q2 Earnings and Revenues (Revised)
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 10:33AM CDT
Alexion's (ALXN) second-quarter 2016 earnings of 93 cents per share surpassed the Zacks Consensus Estimate of 91 cents.
INVA: 13.09 (+1.39), ANIP: 60.18 (+0.57), ALXN: 128.32 (-2.08), NKTR: 16.90 (+0.80)
Glaxo (GSK) Beats Q2 Earnings Estimates, Revenues Up Y/Y
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 9:59AM CDT
Glaxo (GSK) reported second-quarter 2016 core earnings of 70 cents per American depositary share, beating the Zacks Consensus Estimate of 55 cents.
INVA: 13.09 (+1.39), ANIP: 60.18 (+0.57), GSK: 45.15 (-0.03), NVS: 83.14 (+1.06)
Bristol-Myers (BMY) Beats on Q2 Earnings, Lifts Outlook
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 9:43AM CDT
Bristol-Myers' (BMY) delivered better-than-expected second-quarter 2016 earnings and revenues; it raised the 2016 earnings outlook yet again.
INVA: 13.09 (+1.39), ANIP: 60.18 (+0.57), PFE: 36.82 (+0.15), BMY: 74.59 (-0.07)
Bayer (BAYRY) Beats on Q2 Earnings, Updates 2016 Outlook
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:10AM CDT
Bayer's (BAYRY) second-quarter 2016 core earnings of $2.34 per share topped estimates while revenues marginally missed expectations; it revised its 2016 outlook.
MON: 106.01 (-0.11), INVA: 13.09 (+1.39), ANIP: 60.18 (+0.57)
Amgen (AMGN) Tops Q2 Earnings & Revenues, Raises View
Arpita Dutt - Zacks Investment Research - Thu Jul 28, 7:02AM CDT
Amgen (AMGN) once again delivered a "beat and raise" quarter with growth products accounting for more than 50% of product sales.
BIIB: 288.08 (-0.95), INVA: 13.09 (+1.39), AMGN: 171.69 (+0.41), FMS: 45.56 (-0.05)
Vertex (VRTX) Posts Narrower Q2 Loss, Revenues Fall Short
Arpita Dutt - Zacks Investment Research - Thu Jul 28, 6:13AM CDT
Although total revenues were just shy of expectations, Vertex's (VRTX) CF franchise sales improved sequentially.
BIIB: 288.08 (-0.95), VRTX: 96.20 (-0.01), INVA: 13.09 (+1.39), ANIP: 60.18 (+0.57)
What's in Store for VeriSign (VRSN) This Earnings Season?
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 5:51PM CDT
VeriSign, Inc. (VRSN) is set to report second-quarter 2016 results on Jul 28.
VRSN: 86.87 (+2.62), INVA: 13.09 (+1.39), EXPE: 116.53 (-2.74), GDDY: 30.17 (+0.16)
After GILD Earnings, Which Biomed Stock is Best Right Now?
Ryan McQueeney - Zacks Investment Research - Tue Jul 26, 3:55PM CDT
For many investors, Gilead is the go-to stock in the biomed industry. However, with revenues looking sluggish this year, these three Zacks Rank #1 (Strong Buy) stocks might end up being a better bet.
INVA: 13.09 (+1.39), GILD: 79.80 (-1.44), ANIP: 60.18 (+0.57)
Changyou.com (CYOU) Q2 Earnings: Is a Surprise in Store?
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 10:19AM CDT
Changyou.com Limited (CYOU) is set to report second-quarter 2016 results on Aug 1.
INVA: 13.09 (+1.39), EXPE: 116.53 (-2.74), CYOU: 19.82 (-0.12), GDDY: 30.17 (+0.16)
Gilead (GILD) Beats on Q2 Earnings, Cuts 2016 Sales View
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 9:07AM CDT
Gilead Sciences' (GILD) second-quarter 2016 earnings beat the Zacks Consensus Estimate by a penny while revenues missed estimates; product sales outlook is lowered.
INVA: 13.09 (+1.39), FCSC: 1.09 (unch), GILD: 79.80 (-1.44), NKTR: 16.90 (+0.80)
Should You Buy Innoviva (INVA) Ahead of Earnings?
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 7:36AM CDT
Investors are always looking for stocks that are poised to beat at earnings season and Innoviva, Inc. (INVA) may be one such company
INVA: 13.09 (+1.39)
What's in Store for Waste Management (WM) in Q2 Earnings?
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 7:02AM CDT
Waste Management, Inc. (WM) is scheduled to report second-quarter 2016 results before the opening bell on Jul 27.
INVA: 13.09 (+1.39), BMY: 74.59 (-0.07), WM: 66.12 (-0.24), CAA: 36.53 (-3.20)
Will Stericycle (SRCL) Disappoint this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 6:54AM CDT
Stericycle, Inc. (SRCL) is scheduled to report second-quarter 2016 results after the closing bell on Jul 28.
INVA: 13.09 (+1.39), SRCL: 88.24 (-17.69), BMY: 74.59 (-0.07), CAA: 36.53 (-3.20)
Will Ingersoll-Rand (IR) Surpass Q2 Earnings Estimates?
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 3:42AM CDT
Ingersoll-Rand Plc (IR) is scheduled to report second-quarter 2016 results before the opening bell on Jul 27.
INVA: 13.09 (+1.39), IR: 66.42 (-0.04), BMY: 74.59 (-0.07), CAA: 36.53 (-3.20)
Will Synaptics (SYNA) Disappoint Again in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon Jul 25, 4:24PM CDT
Synaptics Inc (SYNA) is set to report fourth-quarter fiscal 2016 results on Jul 28.
INVA: 13.09 (+1.39), SYNA: 52.20 (-1.58), EXPE: 116.53 (-2.74), GDDY: 30.17 (+0.16)
Will Netgear's (NTGR) Earnings in Q2 Spring a Surprise?
Zacks Equity Research - Zacks Investment Research - Mon Jul 25, 8:35AM CDT
Netgear Inc. (NTGR) is set to report second-quarter 2016 results on Jul 27.
INVA: 13.09 (+1.39), EXPE: 116.53 (-2.74), NTGR: 51.65 (-0.70), GDDY: 30.17 (+0.16)